Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.53 USD | -0.09% | +4.34% | +33.14% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.14% | 2.37B | |
+11.75% | 3,123B | |
+10.06% | 86.45B | |
+6.04% | 78.6B | |
-14.66% | 53.98B | |
+26.73% | 48.46B | |
-24.44% | 46.78B | |
+31.74% | 46.36B | |
+82.12% | 42.36B | |
-8.15% | 25.22B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Transcript : Cellebrite DI Ltd., Q3 2023 Earnings Call, Nov 14, 2023